Related Experiment Video
Updated: Jun 23, 2026

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
A U1-U3 snRNA-snoRNA interaction couples SF3B1 mutation to chromatin-state rewiring and genome instability
Abstract:
Mutations in spliceosome factors such as SF3B1 are recurrent across human diseases, including myelodysplastic syndromes and leukemia 1-4 , yet splicing defects alone do not fully explain the widespread chromatin alterations and genome instability in mutant cells 5 . Here, by comprehensively mapping snRNA-directed RNA-RNA interactions, we identify two previously unrecognized interaction motifs in U1 snRNA beyond canonical 5' splice-site pairing 6,7 . These motifs enable U1 RNA to i) bind intronic and other chromatin-associated RNA (caRNA) regions outside of splice sites, and ii) base pair specifically with snoRNA. We uncover a U1-U3 snRNA-snoRNA interaction that recruits the H3K36 methyltransferase SETD2 to caRNA, promoting gene-body H3K36me3 and antagonizing H3K27me3 to modulate chromatin accessibility. The snRNA-snoRNA interface is essential for this previously unrecognized layer of chromatin and transcriptional regulation mediated through SETD2. SF3B1 mutation enhances U1-U3 binding and increases the association of the U1-U3 complex with caRNA, driving chromatin-accessibility remolding, R-loop formation, DNA damage, and copy-number abnormalities that promote tumorigenesis. A U1-specific 2'-O-methoxyethyl antisense oligonucleotide that selectively blocks U1-U3 pairing suppresses these genomic abnormalities, reduces leukemic infiltration, and prolongs survival in xenograft and patient-derived models, establishing pathological snRNA-snoRNA rewiring as a critical driver of SF3B1-mutant leukemogenesis.
Insights
SF3B1 mutations in leukemia disrupt RNA interactions, causing genome instability. Targeting U1-U3 snRNA pairing with antisense oligonucleotides corrects these defects, offering a potential therapeutic strategy for SF3B1-mutant cancers.
Area of Science:
- Molecular Biology
- Cancer Genomics
- RNA Biology
Background:
- Mutations in spliceosome factor SF3B1 are common in myelodysplastic syndromes and leukemia.
- Splicing defects alone do not fully account for chromatin alterations and genome instability in SF3B1-mutant cells.
Purpose of the Study:
- To investigate novel RNA-RNA interactions involving U1 small nuclear RNA (snRNA).
- To elucidate the role of these interactions in SF3B1-mutant leukemogenesis and identify therapeutic targets.
Main Methods:
- Comprehensive mapping of snRNA-directed RNA-RNA interactions.
- Identification of U1 snRNA interaction motifs.
- Analysis of U1-U3 snRNA-snoRNA interactions and SETD2 recruitment.
- Assessment of therapeutic efficacy using antisense oligonucleotides in preclinical models.
Main Results:
- Two new U1 snRNA interaction motifs were identified, enabling binding to intronic/chromatin-associated RNA (caRNA) and snoRNAs.
- A U1-U3 snRNA-snoRNA interaction recruits SETD2 to caRNA, regulating H3K36me3 and H3K27me3.
- SF3B1 mutation enhances U1-U3 binding, leading to chromatin changes, R-loop formation, DNA damage, and copy-number abnormalities.
- A U1-specific antisense oligonucleotide targeting U1-U3 pairing suppressed genomic abnormalities and improved survival in models.
Conclusions:
- Pathological snRNA-snoRNA rewiring is a critical driver of SF3B1-mutant leukemogenesis.
- Targeting the U1-U3 snRNA-snoRNA interaction represents a promising therapeutic strategy for SF3B1-mutant leukemias.
Related Concept Videos
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Chromatin Structure and RNA Splicing
The chromatin structure, especially...
RNA Splicing
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
RNA Stability

